Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 73801-73850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05586581
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
PHASE1/PHASE2Recruiting
70 participants
Started: May 17, 2023 · Completed: Dec 31, 2030
4 conditions3 sponsors1 location
NCT06451211
Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
PHASE2Recruiting
53 participants
Started: May 17, 2023 · Completed: Nov 30, 2027
3 conditions1 sponsor1 location
NCT05879055
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
PHASE2Recruiting
60 participants
Started: May 17, 2023 · Completed: Jan 1, 2028
1 condition1 sponsor13 locations
NCT05855135
Assessment of Combined CCM and ICD Device in HFrEF
NAActive, not recruiting
300 participants
Started: May 17, 2023 · Completed: Jul 31, 2027
10 conditions1 sponsor59 locations
NCT05883553
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
NARecruiting
40 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
5 conditions2 sponsors2 locations
NCT05580861
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
PHASE1/PHASE2Recruiting
64 participants
Started: May 17, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT05433454
Impact of Outreach on Medicaid Enrollment
NAActive, not recruiting
224,000 participants
Started: May 17, 2023 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05921578
Cone-beam CT in the Diagnosis and Surgical Treatment of Otosclerosis.
NARecruiting
100 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05859412
Mechanisms of Neurodynamic Treatments
NARecruiting
108 participants
Started: May 17, 2023 · Completed: Apr 1, 2026
6 conditions2 sponsors1 location
NCT05791864
A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy with TTX-381 for the Ocular Manifestations Associated with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease
PHASE1/PHASE2Recruiting
16 participants
Started: May 17, 2023 · Completed: Jul 30, 2030
1 condition1 sponsor1 location
NCT07021911
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
N/ARecruiting
300 participants
Started: May 17, 2023 · Completed: May 17, 2029
2 conditions1 sponsor1 location
NCT06758011
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
NARecruiting
2,395 participants
Started: May 17, 2023 · Completed: Nov 17, 2026
2 conditions1 sponsor1 location
NCT05456295
Comparative Effect of Carbon Fiber Orthosis Cuff Design on Preference, Comfort, and Mechanics
NAActive, not recruiting
35 participants
Started: May 17, 2023 · Completed: Sep 30, 2026
3 conditions2 sponsors1 location
NCT06750523
Advancing Early Bone Health: New Frontiers for Osteoporosis Prevention
NAActive, not recruiting
200 participants
Started: May 17, 2023 · Completed: Nov 30, 2025
3 conditions3 sponsors2 locations
NCT06763172
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
PHASE4Recruiting
12 participants
Started: May 17, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT06065800
STEELEX® Sternum Set + BONE WAX® + STEELEX® Electrode Set in Patients Undergoing Cardiac Surgery
N/AActive, not recruiting
150 participants
Started: May 17, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05658731
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
NARecruiting
338 participants
Started: May 17, 2023 · Completed: Dec 31, 2035
2 conditions3 sponsors2 locations
NCT05833438
Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
PHASE2Recruiting
45 participants
Started: May 17, 2023 · Completed: Jul 31, 2025
1 condition4 sponsors10 locations
NCT06584617
The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing
NARecruiting
66 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors9 locations
NCT05767021
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3Active, not recruiting
172 participants
Started: May 17, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor120 locations
NCT05860400
Efficacy and Safety of Comprehensive Treatment in Patients with IR-CAD: a Self-controlled Cohort Study
N/ARecruiting
39 participants
Started: May 17, 2023 · Completed: Sep 30, 2025
7 conditions1 sponsor1 location
NCT05467306
Enhancing PrEP Outcomes Among Kenyan Adolescent Girls and Young Women With a Novel Pharmacy-based PrEP Delivery Platform
NARecruiting
1,900 participants
Started: May 17, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05575401
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
NARecruiting
160 participants
Started: May 17, 2023 · Completed: Jan 31, 2026
7 conditions1 sponsor4 locations
NCT05996432
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
EARLY_PHASE1Recruiting
48 participants
Started: May 17, 2023 · Completed: May 31, 2029
2 conditions2 sponsors1 location
NCT05879133
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
NARecruiting
30 participants
Started: May 17, 2023 · Completed: Jul 3, 2027
1 condition2 sponsors1 location
NCT05440227
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
PHASE2Recruiting
36 participants
Started: May 17, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06170840
A Study of QY101 Ointment in Subjects With Plaque Psoriasis
PHASE2Recruiting
160 participants
Started: May 17, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05859997
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
NAEnrolling by invitation
15 participants
Started: May 17, 2023 · Completed: May 27, 2025
6 conditions2 sponsors1 location
NCT05062889
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
PHASE2Recruiting
477 participants
Started: May 17, 2023 · Completed: Dec 31, 2027
4 conditions4 sponsors28 locations
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
PHASE2Recruiting
100 participants
Started: May 17, 2023 · Completed: Nov 4, 2036
1 condition1 sponsor74 locations
NCT05744414
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
N/AActive, not recruiting
30 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05678010
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
PHASE1Active, not recruiting
54 participants
Started: May 17, 2023 · Completed: May 17, 2028
6 conditions2 sponsors5 locations
NCT05444127
Oral Health and Wilson's Disease: SOMAWI
N/ARecruiting
150 participants
Started: May 17, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor3 locations
NCT05752981
Multi-channel Time-resolved Functional Near Infrared Spectroscopy for Prevention of Perioperative Brain Injury
N/ARecruiting
100 participants
Started: May 16, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05804084
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
PHASE2Recruiting
60 participants
Started: May 16, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT05670106
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC
PHASE2Active, not recruiting
62 participants
Started: May 16, 2023 · Completed: Nov 14, 2025
1 condition1 sponsor18 locations
NCT05875103
The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task
NARecruiting
302 participants
Started: May 16, 2023 · Completed: Nov 30, 2029
3 conditions1 sponsor1 location
NCT05897957
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
N/AEnrolling by invitation
12 participants
Started: May 16, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor3 locations
NCT05875038
Superiority of Intelligent Video Surveillance + Telealarm Over Telealarm Alone in Elderly People at Risk of Falling
NARecruiting
395 participants
Started: May 16, 2023 · Completed: Dec 31, 2026
4 conditions12 sponsors1 location
NCT05895305
Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis
EARLY_PHASE1Recruiting
45 participants
Started: May 16, 2023 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT05890287
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
NARecruiting
60 participants
Started: May 16, 2023 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT05889091
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment
NARecruiting
12 participants
Started: May 16, 2023 · Completed: May 16, 2026
1 condition1 sponsor1 location
NCT05844293
Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
PHASE1Recruiting
40 participants
Started: May 16, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor2 locations
NCT05336188
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
PHASE2Recruiting
255 participants
Started: May 16, 2023 · Completed: Sep 30, 2028
7 conditions1 sponsor1 location
NCT06341699
Study of the Steroid Hormone Milieu in Obese Patients
N/ARecruiting
180 participants
Started: May 16, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05683691
Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer
NAActive, not recruiting
400 participants
Started: May 16, 2023 · Completed: Apr 30, 2029
1 condition1 sponsor26 locations
NCT05690685
PMS Study of Silver I Alginate Non-Woven Dressing (Hydro-Alginate)
NARecruiting
60 participants
Started: May 16, 2023 · Completed: Jul 31, 2025
1 condition2 sponsors2 locations
NCT05673928
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
PHASE2Recruiting
30 participants
Started: May 16, 2023 · Completed: Mar 1, 2029
2 conditions3 sponsors1 location
NCT05856435
Tailoring CPP for the Foster Care Setting
NAActive, not recruiting
16 participants
Started: May 16, 2023 · Completed: Aug 30, 2027
1 condition3 sponsors1 location
NCT05265299
Trial to Determine Effective Aspirin Dose in COPD
PHASE3Recruiting
48 participants
Started: May 16, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location